Journey Medical (DERM): microcap biopharma with cash-generating dermatology portfolio and high-upside Emrosi launch. Read here for more analysis.
The updated safety measures will strengthen the MHRA's ability to monitor safe prescribing while supporting patient access to treatment across all age ...
After years of testing hair supplements, growth shampoos, and DIY scalp treatments in hopes of slowing my hair loss, I had ...
In over a decade of building saunas at SaunaCloud, I’ve noticed a pattern: people spend thousands on 'miracle' creams ...
There’s a strange moment that happens the first time you watch botox kick in. One day you’re squinting at your reflection and ...
I have seen behind the scenes of Brand Beckham – it wasn’t always pretty - IN FOCUS: Among the many claims that Brooklyn ...
A pharmacovigilance analysis identified men, older age, and 114 different medications as independent risk factors for ...
Best-Selling Premium Silk Pillowcases Combine Luxury with Dermatologist-Recommended BenefitsNew York, NY - MYK Silk, a ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...